Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOXYNE LIMITED Capital/Financing Update 2007

Mar 22, 2007

64594_rns_2007-03-22_332da67d-059c-4f26-a5d2-c5c1e32085c4.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Problomics Limited ABN 97-084-464-193

Suite G09, 1 Central Avenue Australian Technology Park Eveleigh NSW 1430

$P: +61292094268$ $F: +61292094256$ W: www.probiomies.com.au

The Australian Stock Exchange Limited, Companies Announcements Office, SYDNEY Via: asxonline 23 March 2007

Dear Sirs,

The Board of Directors of Probiomics Limited (ASX code: PCC) is pleased to announce a capital raising of \$400,000 by way of a private placement of shares at \$0.035c per share to a group of 'sophisticated' investors. The placement is made pursuant to ASIC class order 02/1180.

An appendix 3B will follow shortly.

Yours sincerely,

Anopfi

Paul B Magoffin, Company Secretary